Chemoradiotherapy of nonsmall cell lung cancer

References

• Parkin DM, Pisani P, Ferlay J. Global cancer statistics. CA Cancer 1 49,33–64 (1999).
   Google Scholar
• Ihde DC, Minna JD. Non-small cell lung cancer. I. Biology, diagnosis and staging. Cur Pro& Cancer 15,61–104 (1991).
   PubMedGoogle Scholar
• Jassem J. Radiotherapy for non-small cell lung cancer. Lung Cancer 34, S177—S180 (2001).
   Google Scholar
• van Houtte P, Klastersky J, Renaud A et al. Induction chemotherapy with cisplatin, etoposide and vindesine before radiation chemotherapy for non-small cell lung cancer. A randomised study. Antibiot. Chemother. 41,131–137 (1988).
   PubMedGoogle Scholar
• Mattson K, Hoist LP, Hoist P et al Inoperable non-small cell lung cancer: radiation with or without chemotherapy. Eur .j Cancer Clin. Oncol 24,477–482 (1988).
   PubMedGoogle Scholar
• Morton RF, Jett JR, McGinnis WL et al Thoracic radiation therapy alone compared with chemoradiotherapy for locally unresectable non-small cell carcinoma of the lung. Ann. Intern. Med. 115,681–686 (1991).
   PubMed Web of Science ®Google Scholar
• Trovo MG, Minatel E, Veronesi A et al Combined radiotherapy and chemotherapy versus radiotherapy alone in locally advanced epidermoid bronchogenic carcinoma. A randomized study. Cancer65, 400–404 (1990).
   PubMedGoogle Scholar
• Soresi E, Clerici M, Grilli R et al A randomized clinical trial comparing radiation therapy plus cis-dichlorodiammine platinum in the treatment of locally advanced non-small cell lung cancer. Semin. Oncol 15 (Suppl. 7), 20–25 (1988).
   Google Scholar
• Gregor A, Macbeth FR, Paul J et al Radical radiotherapy and chemotherapy in localized inoperable non-small cell lung cancer: a randomized trial. j Nall Cancer Inst. 85, 997–999 (1993).
   PubMedGoogle Scholar
• Planting A, Helle P, Drings P et al. A randomized study of high-dose split course radiotherapy preceded by high-dose chemotherapy versus high-dose radiotherapy only in locally advanced non-small cell lung cancer. An EORTC Lung Cancer Co-operative Group trial. Ann. Oncol 7,139–144 (1996).
   PubMedGoogle Scholar
• Crino L, Latini P, Meacci M et al Induction chemotherapy plus high-dose radiotherapy versus radiotherapy alone in locally advanced unresectable non-small cell lung cancer. Ann. Oncol 4,847–851 (1993).
   PubMedGoogle Scholar
• Wolf M, Hans K, Becker H et al Radiotherapy alone versus chemotherapy with ifosfamide/vindesine followed by radiotherapy in unresectable locally advanced non-small cell lung cancer. Semin. Oncol 21 (Suppl. 4), 42–47 (1994).
   Google Scholar
• Non-small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Br Med. J. 311, 899–909 (1995).
   Google Scholar
• •Meta-analysis of 22 trials (3033 patients) addressing the role of chemotherapy in addition to radiotherapy in locally advanced NSCLC.
   Google Scholar
• Mattson K, Hoist LP, Hoist P et al Inoperable non-small cell lung cancer: radiation with or without chemotherapy. Eur j Cancer Clin. Oncol 24, 477–482 (1988).
   PubMedGoogle Scholar
• Morton RF, Jett JR, McGinnis WL et al. Thoracic radiation therapy alone compared with chemoradiotherapy for locally unresectable non-small cell carcinoma of the lung. Ann. Intern Med 115, 681–686 (1991).
   PubMed Web of Science ®Google Scholar
• Arriagada R, Le Chevalier T, Rekacewicz E et al Cisplatin-based chemotherapy (CT) in patients with locally advanced non-small cell lung cancer (NSCLC): late analysis of a French randomized trial. Proc. Am. Soc. Clin. Oncol 16,446a (1997).
   Google Scholar
• Dillman RO, Herndon J, Seagren SL et al Improved survival in stage III non-small cell lung cancer: seven-year follow-up of cancer and leukemia group B [CALGB] 8433 trial. Nati Cancer Inst. 88,1210–1214 (1996).
   PubMed Web of Science ®Google Scholar
• Sause W, Kolesar P, Taylor S et al Final results of Phase III trial in regionally advanced unresectable non-small cell lung cancer. Chest 117,358–364 (2000).
   PubMed Web of Science ®Google Scholar
• •A large, randomized study demonstrating a survival benefit from the addition of induction chemotherapy to radiation and an intermediate efficacy of hyperfractionated radiotherapy.
   Google Scholar
• Brodin O, Nou E, Mercke C et al. Comparison of induction chemotherapy before radiotherapy with radiotherapy only in patients with locally advanced squamous cell carcinoma of the lung. Eur J Cancer 32A, 1893–1890 (1996).
   PubMedGoogle Scholar
• Cullen MET, Billingham U, Woodrofee CM et al. Mitomycin, ifosfamide and cisplatin in unresectable non-small cell lung cancer: effects on survival and quality of life. Clin. Oncol 17,3188–3194 (1999).
   Google Scholar
• Schaake-Koning C, Van den Bogaert W Dalesio O et al. Effects of concomitant cisplatin and radiotherapy on inoperable non-small cell lung cancer. N Engl. J. Med. 326,524–530 (1992).
   Google Scholar
• •A large three-arm randomized trial demonstrating a considerable survival benefit from the addition of low daily cisplatin doses to radiation in inoperable NSCLC.
   Google Scholar
• Trovo NG, Minotel E, Fravelun G et al Radiotherapy versus radiotherapy enhanced by cisplatin in stage III non-small cell lung cancer. Int. J Radiat. Oncol Biol. Phys. 24, 11–16 (1992).
   PubMed Web of Science ®Google Scholar
• Ball D, Bishop J, Smith J et al A randomized Phase III study of accelerated or standard fraction radiotherapy with or without concurrent carboplatin in inoperable non-small cell lung cancer: final report of an Australian multi-centre trial. Radiother. Oncol 52,129–136 (1999).
   PubMedGoogle Scholar
• Clamon G, Herndon J, Cooper R et al Radiosensitization with carboplatin for patients with unresectable Stage III non-small cell lung cancer: a Phase III trial of the Cancer and Leukemia Group B and the
   Google Scholar
• ••Eastern Co-operative Oncology Group. Clin. Oncol 17, 4–11 (1999).
   Google Scholar
• Blanke C, Ansari R, Montravadi R et al. A Phase III trial of thoracic irradiation with and without concomitant cisplatin for locally advanced unresectable non-small cell lung cancer: a Hoosier Oncology Group study. Clin. Oncol 13, 1425–1429 (1995).
   Google Scholar
• Trovo MG, Minatel E, Veronesi A et al Combined radiotherapy and chemotherapy versus radiotherapy alone in locally advanced epidermoid bronchogenic carcinoma. A randomized study. Cancer 65, 400–404 (1990).
   PubMedGoogle Scholar
• Jeremic B, Shibamoto Y, Acimovic L et al Randomized trial of hyperfractionated radiation therapy with or without concurrent chemotherapy for Stage III non-small cell lung cancer. j Clin. Oncol. 13, 452–458 (1995).
   PubMed Web of Science ®Google Scholar
• Jeremic B, Shibamoto Y, Acimovic L et al Hyperfractionated radiation therapy with or without concurrent low-dose daily carboplatin/etoposide for Stage III non-small cell lung cancer: a randomized study. Clin. Oncol. 14, 1065–1070 (1996).
   Google Scholar
• •A randomized study showing the survival benefit associated with concomitant application of platinum-based chemotherapy and hyperfractionated radiation as compared with radiation alone.
   Google Scholar
• Jeremic B, Jevremovic S, Mijatovic L et al Hyperfractionated radiation therapy with and without concurrent chemotherapy for advanced non-small cell lung cancer. Cancer 71, 3732–3736 (1993).
   PubMedGoogle Scholar
• Furuse K, Fukuoka M, Kawahara M et al. Phase III study of concurrent vs. sequential thoracic radiotherapy in combination with mitomycin, vindesine and cisplatin in unresectable stage III non-small cell lung cancer: five-year median follow-up results. Clin. Oncol 17, 2692–2699 (1999). A large randomized study demonstrating the superiority of concomitant chemoradiotherapy as compared with sequential chemotherapy and radiotherapy.
   Google Scholar
• Movsas B, Scott C, Curran W A quality- adjusted time without symptoms or toxicity (QTWiST). Analysis of Radiation Therapy Oncology Group [RTOG] 9410. Proc. Am. Soc. Clin. Oncol 20, 313a (2001) (Abstract).
   Google Scholar
• Langer CJ, Hsu C, Curran WJ et al. Elderly patients (pts) with locally advanced non-small cell lung cancer (LA-NSCLC) benefit from combined modality therapy: secondary analysis of Radiation Therapy Oncology Group (RTOG) 94–10. Proc. Am. Soc. Clin. Oncol. 21, 299a (2002).
   Google Scholar
• Mornex F, Robinet G, Thomas P et al Sequential versus concurrent chemo-radiation (RT-CT) in locally advanced non-small cell lung cancer (NSCLC): a French randomized Phase III trial of GLUT-GFPC (NPC 95–01 study). Eur.j Cancer 37 (Suppl. 6), S29 (2001).
   Google Scholar
• Zatloukal PV, Petruzelka L, Zemanova M et al Concurrent versus sequential radiochemotherapy with vinorelbine plus cisplatin (V-P) in locally advanced non-small cell lung cancer. A randomized Phase II study. Proc. Am Soc. Clin. awl 21, 291a (2002).
   Google Scholar
• Choy H, Browne MJ. Paclitaxel as a radiation sensitizer in non-small cell lung cancer. Semin. Oncol 22, 70–74 (1995).
   PubMed Web of Science ®Google Scholar
• Mason IKA, Hunter NR, Milas M et al Docetaxel enhances tumor radioresponse in vivo. Clin. Cancer Res. 3, 2431–2438 (1997).
   PubMedGoogle Scholar
• Koukourakis MI, Bahlitzanakis N, Froudarakis M et al Concurrent conventionally fractionated radiotherapy and weekly docetaxel in the treatment of stage Mb non-small cell lung carcinoma. Br. Cancer80, 1792–1796 (1999).
   Google Scholar
• Choy H, Safran H, Akerley W, et al Phase II trial of weekly paclitaxel and concurrent radiation therapy for locally advanced non-small cell lung cancer. Clin. Cancer Res. 4, 1931–1936 (1998).
   PubMed Web of Science ®Google Scholar
• Goor C, Scalliet P, van Meerbeck J et al A Phase II study combining gemcitabine with radiotherapy in Stage III NSCLC. Ann. Oncol 7, 101 (1996).
   Google Scholar
• Vokes EE, Gregor A, Turrisi AT Gemcitabine and radiation therapy for non-small cell lung cancer. Semin. Oncol 25 (Suppl. 9), 66–69 (1998).
   Google Scholar
• Gralla R, Harper P, Johnson S al Vinorelbine (navelbine) in the treatment of non-small cell lung cancer: recent developments in combination chemotherapy and radiotherapy. Ann. Oncoll0\(Suppl. 5), S47-51 (1999).
   Google Scholar
• Vokes EE, Leopold IKA, Herndon JE et al CALGB Study 9431: a randomized Phase II study of cisplatin with gemcitabine or paclitaxel or vinorelbine as induction chemotherapy (Ind CT) and concomitant chemoradiotherapy (XRT) for unresectable stage III non-small cell lung cancer (NSCLC) . Lung Cancer 29 (suppl. 1), 49 (2000) (Abstract).
   Google Scholar
• Jassem J. Combined chemotherapy and radiation in locally advanced non-small cell lung cancer. Lancet Oncol. 2, 335–342 (2001).
   PubMedGoogle Scholar
• American Society of Clinical Oncology. Clinical practice guidelines for the treatment of unresectable non-small cell lung cancer. J. Clin. Oncol 15, 2996–3018 (1997).
   PubMed Web of Science ®Google Scholar
• Miller EM, Kinsella TJ. Radiosensitization by fluorodexouridine: effects of thymidilate synthasae inhibition and cell synchronization. Cancer Res. 51, 1687–1694 (1992).
   Google Scholar
• Milas L, Mason K, Hunter N et al In vivo enhancement of tumor radioresponse by C225 anti-epidermal growth factor receptor antibody. Clin. Cancer Res. 6, 701–708 (2000).
   Google Scholar
• Cohen-Jonathan E, Muschel RJ, Gillies McKenna W et al Famesyltransferase inhibitors potentiate the antitumor effect of radiation on a human xenograft expressing activated HRAS. Racliat. Res. 154, 125–132 (2000).
   Google Scholar
• Mauceri HJ, Hanna NN, Becket MA et al Combined effect of angiostatin and ionizing radiation in antitumour therapy. Nature 394, 287–291 (1998).
   PubMed Web of Science ®Google Scholar